Drug development: innovation or imitation deficit?

Morgan, S G and Cunningham, C and Law, M R (2012) Drug development: innovation or imitation deficit? British Medical Journal, 345 (e5880). ISSN 0959-8138

Full text not available from this repository.
Official URL: http://www.bmj.com/content/345/bmj.e5880


Light and Lexchin argue that the pharmaceutical innovation crisis is a myth.1 Although they correctly diagnose the issue, the drug approval data provided tell only half of the story. To shed more light on drug development trends, we classified US Food and Drug Administration approvals of new drugs (therapeutic new molecular entities) into one of three mutually exclusive categories: first-of-kind drugs to be approved within chemical or …

Item Type: Article
Subjects: R > Research and development
P > Pharmaceutical industry
Subject Areas: Strategy and Entrepreneurship
DOI: 10.1136/bmj.e5880
Date Deposited: 31 Aug 2017 15:41
Last Modified: 01 Sep 2017 09:24
URI: http://lbsresearch.london.edu/id/eprint/871

Actions (login required)

Edit Item Edit Item